Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Region Hovedstadens forskningsportal Forside
Dansk
English
Søg efter indhold i Region Hovedstadens forskningsportal
Forside
Hospitaler/Afdelinger
Forskere
Publikationer
Aktiviteter
Priser
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S Sabatine
, Robert P Giugliano
, Anthony C Keech
, Narimon Honarpour
, Stephen D Wiviott
, Sabina A Murphy
, Julia F Kuder
, Huei Wang
, Thomas Liu
, Scott M Wasserman
, Peter S Sever
, Terje R Pedersen
, FOURIER Steering Committee and Investigators
, Jørgen Lykke Jeppesen
Medicinsk Afdeling, Glostrup
5618
Citationer (Scopus)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Keyphrases
Clinical Outcomes
100%
Cardiac Patients
100%
Evolocumab
100%
Low-density Lipoprotein Cholesterol Level
85%
Placebo
42%
Cardiovascular Mortality
28%
Hazard Ratio
28%
Statin Therapy
28%
95% Confidence Interval
28%
Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9)
28%
Cardiovascular Events
14%
Myocardial Infarction
14%
No Significant Difference
14%
Adverse Events
14%
Randomized Placebo-controlled Trial
14%
Hospitalization
14%
Stable Angina
14%
Fourier
14%
Injection Site Reaction
14%
Subcutaneous Injection
14%
Monoclonal Antibody
14%
Least Mean Square
14%
Coronary Revascularization
14%
New-onset Diabetes
14%
Neurocognitive
14%
Amgen
14%
Cardiovascular Risk Factors
14%
Myocardial Infarction Stroke
14%
Every 2 weeks
14%
Pharmacology, Toxicology and Pharmaceutical Science
Evolocumab
100%
Cardiovascular Disease
100%
Low Density Lipoprotein Cholesterol
85%
Placebo
57%
Heart Infarction
28%
Statin (Protein)
28%
Coronary Artery Atherosclerosis
28%
Cerebrovascular Accident
28%
Proprotein Convertase 9
28%
Adverse Event
14%
Unstable Angina Pectoris
14%
Injection Site Reaction
14%
Subcutaneous Injection
14%
Monoclonal Antibody
14%